How will Ohio's cannabis market shape up as it transitions to adult-use recreational sales? Senior analyst Pablo Zuanic outlines in his recent report the potential growth and value creation for state multi-state operators (MSOs). Zuanic’s…
TDR Research has recently initiated coverage of multi-state cannabis company Trulieve (OTC: TCNNF), assigning it a “Buy” rating based on an extensive analysis of the company's financial health and growth potential. The report highlights…
The potential rescheduling of cannabis in the U.S. and the growing demand in Germany positions InterCure (NASDAQ: INCR), the leading seller of pharmaceutical cannabis outside North America, to capitalize on these opportunities, according…
Akanda implements a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024. The new CUSIP number for the ordinary shares following the reverse stock split is 00971M304.
TILT Holdings' (OTC: TLLTF) first-quarter 2024 results reveal disruptions in the vape hardware segment, which accounts for 71% of the company's sales in 2023. Pablo Zuanic from Zuanic & Associates notes, "Disruptions on the supply side of…
According to a recent report by Pablo Zuanic of Zuanic & Associates, MariMed (OTC: MRMD) a multi-state cannabis operator (MSO) is positioned for significant stock gains.
The Department of Justice (DOJ) move to reclassifying cannabis from Schedule I to Schedule III provoked a noticeable uptick in cannabis market activities, as detailed in the latest industry report by Water Tower Research (WTR).
The trading volume of a stock reflects the number of shares bought and sold within a given time. This is called liquidity. The term is used because it likens the ease of converting assets to cash to the fluidity of water. Why is this…
Four lesser-valued cannabis stocks showed positive performance on Monday, defying the broader sector's downtrend. These stocks—Medical Marijuana Inc., TILT Holdings, Trees Corp., and Village Farms International —present potential…
The Department of Justice (DOJ) confirmed that it has started the formal rulemaking process to reclassify cannabis to Schedule III. This significant step reinforces the positive outlook for cannabis stocks.
Michael Berger, founder of Technical420, managing partner of StoneBridge Partners and the beloved maven behind Benzinga Cannabis Research, our cannabis stock analysis and trading subscriber-only platform, tragically passed away last…
The Department of Justice reportedly planned to issue a notice of proposed rulemaking on Thursday that would reclassify marijuana to Schedule III after a 60-day public comment period. Major players in the marijuana industry, including…
Tilray Brands is getting ready for marijuana to be reclassified as a less dangerous drug in the U.S., as the cannabis company is looking to raise money through the sale of shares so it can expand.